[go: up one dir, main page]

NO20030233L - Fremgangsmåte for å finne forbindelser som er egnet for behandling og/ellerprofylakse av fedme - Google Patents

Fremgangsmåte for å finne forbindelser som er egnet for behandling og/ellerprofylakse av fedme

Info

Publication number
NO20030233L
NO20030233L NO20030233A NO20030233A NO20030233L NO 20030233 L NO20030233 L NO 20030233L NO 20030233 A NO20030233 A NO 20030233A NO 20030233 A NO20030233 A NO 20030233A NO 20030233 L NO20030233 L NO 20030233L
Authority
NO
Norway
Prior art keywords
prophylaxis
obesity
treatment
compounds suitable
finding compounds
Prior art date
Application number
NO20030233A
Other languages
English (en)
Other versions
NO20030233D0 (no
Inventor
Johannes Hebebrand
Jochen Antel
Ulf Preuschoff
Samuel David
Holger Sann
Michael Weske
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20030233D0 publication Critical patent/NO20030233D0/no
Publication of NO20030233L publication Critical patent/NO20030233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20030233A 2000-07-20 2003-01-17 Fremgangsmåte for å finne forbindelser som er egnet for behandling og/ellerprofylakse av fedme NO20030233L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (2)

Publication Number Publication Date
NO20030233D0 NO20030233D0 (no) 2003-01-17
NO20030233L true NO20030233L (no) 2003-03-19

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030233A NO20030233L (no) 2000-07-20 2003-01-17 Fremgangsmåte for å finne forbindelser som er egnet for behandling og/ellerprofylakse av fedme

Country Status (27)

Country Link
EP (1) EP1307262B1 (no)
JP (1) JP2004504053A (no)
KR (1) KR100818827B1 (no)
CN (1) CN1443085B (no)
AR (1) AR028730A1 (no)
AT (1) ATE278441T1 (no)
AU (2) AU7753401A (no)
BR (1) BR0112547A (no)
CA (1) CA2416647A1 (no)
CZ (1) CZ2003156A3 (no)
DE (2) DE10035227A1 (no)
DZ (1) DZ3393A1 (no)
ES (1) ES2230346T3 (no)
HK (1) HK1057499A1 (no)
HU (1) HUP0302309A3 (no)
IL (2) IL153971A0 (no)
MX (1) MXPA02012907A (no)
NO (1) NO20030233L (no)
NZ (1) NZ523960A (no)
PL (1) PL201165B1 (no)
PT (1) PT1307262E (no)
RU (1) RU2268721C2 (no)
SK (1) SK287607B6 (no)
TR (1) TR200402670T4 (no)
TW (1) TWI274157B (no)
UA (1) UA74588C2 (no)
WO (1) WO2002007821A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510137A (pt) 2004-05-19 2007-10-02 Solvay Pharm Gmbh medicamentos contendo n-sulfamoil-n'-arilpiperazinas para a profilaxia ou tratamento da obesidade e condições relacionadas
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CN101754947A (zh) 2005-05-20 2010-06-23 詹森药业有限公司 磺酰胺衍生物的制备方法
TW200804393A (en) 2005-11-14 2008-01-16 Solvay Pharm Gmbh Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
WO2008089521A1 (en) 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
PE20110060A1 (es) 2008-06-23 2011-01-31 Janssen Pharmaceutica Nv Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CA2874513A1 (en) * 2012-05-24 2013-11-28 Verva Pharmaceuticals Ltd A method of improving liver function
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DK0669832T3 (da) * 1992-10-29 1997-03-17 Genentech Inc Fremgangsmåde til behandling eller forebyggelse af fedme
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
CN1106193C (zh) * 1996-06-28 2003-04-23 奥索·麦克尼尔药品公司 抗惊厥剂氨基磺酸酯衍生物用于治疗肥胖的用途
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
HUP0302309A3 (en) 2005-06-28
CA2416647A1 (en) 2003-01-20
UA74588C2 (en) 2006-01-16
RU2268721C2 (ru) 2006-01-27
AU2001277534B2 (en) 2005-09-29
PL363518A1 (en) 2004-11-29
AU7753401A (en) 2002-02-05
NO20030233D0 (no) 2003-01-17
JP2004504053A (ja) 2004-02-12
ES2230346T3 (es) 2005-05-01
NZ523960A (en) 2004-12-24
PT1307262E (pt) 2004-12-31
SK612003A3 (en) 2003-06-03
HK1057499A1 (en) 2004-04-08
DE10035227A1 (de) 2002-01-31
CZ2003156A3 (cs) 2003-06-18
CN1443085B (zh) 2010-04-28
AU2001277534B9 (en) 2006-02-23
MXPA02012907A (es) 2003-09-22
TWI274157B (en) 2007-02-21
HUP0302309A2 (hu) 2003-11-28
IL153971A0 (en) 2003-07-31
KR100818827B1 (ko) 2008-04-01
IL153971A (en) 2009-07-20
BR0112547A (pt) 2003-07-01
EP1307262B1 (de) 2004-10-06
DZ3393A1 (fr) 2002-01-31
CN1443085A (zh) 2003-09-17
EP1307262A1 (de) 2003-05-07
TR200402670T4 (tr) 2004-11-22
DE50104023D1 (de) 2004-11-11
WO2002007821A1 (de) 2002-01-31
PL201165B1 (pl) 2009-03-31
KR20030022284A (ko) 2003-03-15
SK287607B6 (sk) 2011-03-04
ATE278441T1 (de) 2004-10-15
AR028730A1 (es) 2003-05-21

Similar Documents

Publication Publication Date Title
NO20030233L (no) Fremgangsmåte for å finne forbindelser som er egnet for behandling og/ellerprofylakse av fedme
NO20054369D0 (no) Anvendelse av en IBAT-inhibitor for behandling og profylakse av forstoppelse
NO20013380D0 (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20020770L (no) Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av obesitas
AU8870701A (en) Materials and methods for the treatment or prevention of obesity
AU2001271567A1 (en) Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
NO20035610L (no) Fremgangsmate for behandling av vaeskeformig hydrokarbon
NO20044195L (no) Biofosfoninsyrer for behandling og prevensjon av osteoprose
NO20052476D0 (no) 2-alkyl-(2-amino-3-aryl-propionyl)-piperazinderivater og beslektede forbindelser som melanokortinreseptorligander for behandlingen av obesitet.
GB2418025B (en) Device for the prevention or treatment of ulcers
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
NO20033498L (no) Fremgangsmåte for behandling og törking av trevirke
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
ATE498402T1 (de) Clc-2-kanalöffner zur behandlung von magen- oder darm-ulcus
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
SI1562577T1 (sl) Acetyl-L-karnitin za preprečevanje in/ali zdravljenje perifernih nevropatij, induciranih s talidomidom
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
NO20052264D0 (no) Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser
AU2001239301A1 (en) Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
AU2000272704A1 (en) Use of compounds for the treatment of obesity